Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion type Assertion NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_head.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion description "[Many of these mutations, particularly those leading to the activation of the MAPK pathway, are being actively explored as therapeutic targets for thyroid cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_provenance.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion evidence source_evidence_literature NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_provenance.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion SIO_000772 18437172 NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_provenance.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion wasDerivedFrom befree-20140225 NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_provenance.
- NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_assertion wasGeneratedBy ECO_0000203 NP615626.RAYW9zyhVShIP_VlV7HKuk25zLl7jRYBpySCEUwNm1AHU130_provenance.